Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate in osteosarcoma

Pediatric Nephrology

Volumn 12, Issue 7, 1998, Pages 572-575

  Nogueira, Paulo C Koch ^a,d   Hadj Aïssa, Aoumeur ^b   Schell, Mathias ^c   Dubourg, Laurence ^a,b   Brunat Mentigny, Maud ^c   Cochat, Pierre ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c CENTRE LÉON BÉRARD   (France)

^d Department of Cardiovascular Surgery   (Brazil)

Author keywords

Cisplatin; Ifosfamide; Methotrexate; Nephrotoxicity; Osteosarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM ION; CHLORIDE ION; CISPLATIN; CREATININE; IFOSFAMIDE; MAGNESIUM ION; METHOTREXATE; PHOSPHORUS; POTASSIUM ION; SODIUM ION; URIC ACID;

ADOLESCENT; ADULT; ARTICLE; CALCIUM URINE LEVEL; CHLORIDE URINE LEVEL; CLINICAL ARTICLE; CREATININE CLEARANCE; FEMALE; HUMAN; HYPERCALCIURIA; HYPOMAGNESEMIA; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; LONG TERM CARE; MAGNESIUM URINE LEVEL; MALE; MICROALBUMINURIA; NEPHROTOXICITY; OSTEOSARCOMA; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; SCHOOL CHILD; SODIUM URINE LEVEL; URIC ACID URINE LEVEL;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CISPLATIN; CREATININE; FEMALE; HUMANS; IFOSFAMIDE; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; METHOTREXATE; OSTEOSARCOMA;

EID: 7344248010     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050507     Document Type: Article

References (18)

1. Schärer K (1986) Nephrotoxicity action of immunosuppressive and cytostatic agents. Helv Paediatr Acta 41:103-104
2. Daugaard G, Abildgaard U (1989) Cisplatin nephrotoxicity. Cancer Chemother Pharmacol 25:1-9
3. Stevens MCG, Brandis M (1993) Incidence and etiology of ifosfamide nephrotoxicity. Med Pediatr Oncol 21:640-644
4. Condit PT, Chanes RE, Joel W (1969) Renal toxicity of methotrexate. Cancer 23:126-131
5. Dalla-Vale F, Cochat P, Bouffet E, Frappaz D, Bigot P, Vial M, Glastre C, Floret D (1994) Intoxication aiguë au methotrexate: intérêt de l'hémodialyse couplée à l' hémoperfusion sur charbon activé. Ann Pédiatr (Paris) 41:60-63
6. Goren MP; Wright RK, Pratt CB, Horowitz ME, Dodge RK, Viar MJ, Kovnar EH (1987) Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum (II) therapy. Cancer Res 47:1457-1460
7. Shore R, Greenberg M, Geary D, Koren G (1992) Iphosphamide-induced nephrotoxicity in children. Pediatr Nephrol 6:162-165
8. Pratt CB, Meyer WH, Jenkins JJ, Avery L, McKay CP, Wyatt RJ, Hancock ML (1991) Ifosfamide, Fanconi's syndrome and rickets. J Clin Oncol 9:1495-1499
9. Rossi R, Danzebrink S, Hillebrand D, Linnenbürger K, Ullrich K, Jürgens H (1994) Ifosfamide-induced subclinical nephrotoxicity and its potentiation by cisplatinum. Med Pediatr Oncol 22:27-32
10. Suarez A, McDowell H, Niaudet P, Comoy E, Flamant F (1991) Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an international society of pediatric oncology report. J Clin Oncol 9:2177-2182
11. Bianchetti MG, Kanaka C, Ridolfi-Lüthy A, Hirt A, Wagner HP, Oetliker OH (1991) Persisting renotubular sequelae after cisplatin in children and adolescents. Am J Nephrol 11:127-130
12. 2 of ifosfamide. Cancer Chemother Pharmacol 34:431-433
13. Skinner R, Pearson ADJ, English MW, Price L, Wyllie RA, Coulthard MG, Craft AW (1996) Risk factors for ifosfamide nephrotoxicity in children. Lancet 348:578-580
14. Skinner R, Pearson ADJ, Coulthard MG, Skillen AW, Hodson AW, Goldfinch ME, Gibb I, Craft AW (1991) Assessment of chemotherapy-associated nephrotoxicity in children with cancer. Cancer Chemother Pharmacol 28:91-92
15. Jones DP, Chesney RW (1995) Renal toxicity of cancer chemotherapeutic agents in children: ifosfamide and cisplatin. Curr Opin Pediatr 7:208-213
16. Heney D, Wheeldon J, Rushworth P, Chapman C, Lewis IJ, Bailey CC (1991) Progressive renal toxicity due to ifosfamide. Arch Dis Child 66:966-970
17. Brock PR, Koliouskas DE, Barratt TM, Yeomans E, Pritchard J (1991) Partial reversibility of cisplatin nephrotoxicity in children. J Pediatr 118:531-534
18. Brillet G, Deray G, Jacquiaud C, Mignot L, Brunker D, Meillet D, Raymond F, Jacobs C (1994) Long-term renal effect of cisplatin in man. Am J Nephrol 14:81-84